AGL
Agilon Health, Inc.NYSEHealthcare$10.74+29.98%ClosedMarket Cap: $178.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.83
P/S
0.04
EV/EBITDA
-0.26
DCF Value
$-4,318.03
FCF Yield
-60.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-2.9%
Operating Margin
-7.1%
Net Margin
-6.6%
ROE
-116.6%
ROA
-30.8%
ROIC
-196.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.57B | -6.2% | $-155.8M | $-188.9M | $-11.50 | — |
| FY 2025 | $5.93B | -3.2% | $-421.1M | $-405.3M | $-24.50 | — |
| Q3 2025 | $1.44B | -5.2% | $-127.2M | $-110.2M | $-6.75 | — |
| Q2 2025 | $1.39B | -3.8% | $-116.0M | $-104.4M | $-6.25 | — |
| Q1 2025 | $1.53B | 3.3% | $-22.1M | $12.1M | $0.75 | — |
| Q4 2024 | $1.52B | -2.5% | $-108.1M | $-105.8M | $-6.50 | — |
| FY 2024 | $6.06B | 0.1% | $-292.1M | $-260.2M | $-15.75 | — |
| Q3 2024 | $1.45B | -4.4% | $-133.5M | $-117.6M | $-7.25 | — |
| Q2 2024 | $1.48B | 2.2% | $-43.3M | $-30.7M | $-1.75 | — |
| Q1 2024 | $1.60B | 4.7% | $-7.2M | $-6.1M | $-0.25 | — |
| Q4 2023 | $815.5M | -11.7% | $-159.6M | $-230.4M | $-14.00 | — |
| FY 2023 | $4.32B | 1.6% | $-232.1M | $-262.6M | $-16.00 | — |